American Heart Association Journals Circulation Representing the best in the field of cardiovascular medicine and science as well as basic science Editor-in-Chief: Joseph A Hill, MD, PhD View latest issue
American Heart Association Journals Circulation Research The premier international journal in basic and translational cardiovascular biology and source for the most revolutionary research in the field Editor-in-Chief: Jane E Freedman, MD View latest issue
Circulation | Instructions for Authors | AHA ASA Journals Circulation Specific Requests Authors are encouraged to include the following items when submitting an Original Research manuscript Clinical Perspective: As a benefit to our readers, include a Clinical Perspective section within the manuscript, which should provide a concise summary of the key observations and their clinical relevance, written for the clinical cardiology audience Address the
| AHA ASA Journals Circulation publishes original research manuscripts, review articles, and other content related to cardiovascular health and disease, including observational studies, clinical trials, epidemiology, health services and outcomes studies, and advances in basic and translational research
Circulation | Instructions for Authors | AHA ASA Journals Circulation publishes original research manuscripts, review articles, and other invited content related to cardiovascular health and disease, including observational studies, clinical trials, epidemiology, health services and outcomes studies, and advances in basic and translational research
American Heart Association Journals Circulation: Heart Failure presents Waveforms, our blog highlighting what’s new and what’s important about papers coming out in the journal Latest Posts
American Heart Association Journals Circulation: Cardiovascular Quality and Outcomes: Current Issue 2025 AHA ACC Clinical Performance and Quality Measures for Patients With Chronic Coronary Disease: A Report of the American College of Cardiology American Heart Association Joint Committee on Performance Measures
Reactivation of Oxidized Soluble Guanylate Cyclase as a Novel Treatment . . . BACKGROUND: Pharmacological treatments for fibrocalcific aortic valve stenosis (FCAVS) have been elusive for gt;50 years Here, we tested the hypothesis that reactivation of oxidized sGC (soluble guanylate cyclase), the primary receptor for nitric oxide, with ataciguat is a safe and efficacious strategy to slow progression of FCAVS METHODS: We used quantitative real-time reverse